Hey future & Mal
I'm a holder of 3+ yrs. Accumulating as I’ve gone along.
I have faith in the concept.
I have frustration in the implementation.
It seems you're both quite right...
- statistics of take up are looking promising.
- world domination is in the pipeline.
- share price responding gradually.
- users counted in app, but not actually using
- revenue not being generated despite take up.
IMO the slow build of acceptance of this product needs to be accelerated. MDR should (once numbers online are as expected) shift from billing per pharmacy to billing per transaction - think eftpos surcharge already accepted across Australia.
lastly, I’d like to see Rob generate more retail investor hype and get this product on radar of traders. All exposure is good exposure.
If this company reaches its potential, locally and globally. Let the SP grow.
GLTAH
Add to My Watchlist
What is My Watchlist?
